BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sang Z, Wang K, Shi J, Liu W, Cheng X, Zhu G, Wang Y, Zhao Y, Qiao Z, Wu A, Tan Z. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. Eur J Med Chem 2020;192:112180. [PMID: 32131034 DOI: 10.1016/j.ejmech.2020.112180] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Miao S, He Q, Li C, Wu Y, Liu M, Chen Y, Qi S, Gong K. Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent. Pharmaceutical Biology 2022;60:1502-10. [DOI: 10.1080/13880209.2022.2102657] [Reference Citation Analysis]
2 Wu J, Zhang H, Wang Y, Yin G, Li Q, Zhuo L, Chen H, Wang Z. From tryptamine to the discovery of efficient multi-target directed ligands against cholinesterase-associated neurodegenerative disorders. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1036030] [Reference Citation Analysis]
3 Zhang H, Peng Y, Zhuo L, Wang Y, Zeng G, Wang S, Long L, Li X, Wang Z. Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy. Eur J Med Chem 2022;242:114695. [PMID: 36044812 DOI: 10.1016/j.ejmech.2022.114695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu J, Li X, Liang J, Fang D, Yang Z, Wei J, Chen Z. Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme. Front Genet 2022;13:940462. [DOI: 10.3389/fgene.2022.940462] [Reference Citation Analysis]
5 Sang Z, Wang K, Dong J, Tang L. Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress. European Journal of Medicinal Chemistry 2022;238:114464. [DOI: 10.1016/j.ejmech.2022.114464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Sang Z, Bai P, Ban Y, Wang K, Wu A, Mi J, Hu J, Xu R, Zhu G, Wang J, Zhang J, Wang C, Tan Z, Tang L. Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies. Bioorg Chem 2022;127:106007. [PMID: 35849893 DOI: 10.1016/j.bioorg.2022.106007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Yang X, Yang W, Xia X, Lei T, Yang Z, Jia W, Zhou Y, Cheng G, Gao H. Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease Therapy. Small 2022;:e2203182. [PMID: 35771092 DOI: 10.1002/smll.202203182] [Reference Citation Analysis]
8 Vicente-zurdo D, Rosales-conrado N, León-gonzález ME, Brunetti L, Piemontese L, Pereira-santos AR, Cardoso SM, Madrid Y, Chaves S, Santos MA. Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer’s Disease. Biomedicines 2022;10:1510. [DOI: 10.3390/biomedicines10071510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Su YL, Liu D, Liu YJ, Ji YL, Liu GS, Wang JL, Wang B, Wang H. Phlorizin alleviates cholinergic memory impairment and regulates gut microbiota in d-galactose induced mice. Exp Gerontol 2022;:111863. [PMID: 35660419 DOI: 10.1016/j.exger.2022.111863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zhu G, Bai P, Wang K, Mi J, Yang J, Hu J, Ban Y, Xu R, Chen R, Wang C, Tang L, Sang Z. Design, synthesis, and evaluation of novel O-alkyl ferulamide derivatives as multifunctional ligands for treating Alzheimer's disease. J Enzyme Inhib Med Chem 2022;37:1375-88. [PMID: 35549612 DOI: 10.1080/14756366.2022.2073442] [Reference Citation Analysis]
11 Deng C, Mi J, Zhou Y, Li X, Liu Z, Sang Z, Li H. Design, synthesis, and biological evaluation of novel 2-acetylphenol-rivastigmine hybrids as potential multifunctional agents for the treatment of Alzheimer’s disease. Med Chem Res. [DOI: 10.1007/s00044-022-02899-7] [Reference Citation Analysis]
12 Frank A, Hamidi N, Xue F. Regioselective alkylation of 2,4-dihydroxybenzyaldehydes and 2,4-dihydroxyacetophenones. Tetrahedron Letters 2022;95:153755. [DOI: 10.1016/j.tetlet.2022.153755] [Reference Citation Analysis]
13 Hisham M, Hassan HA, Gomaa HA, Youssif BG, Hayallah AM, Abdel-aziz M. Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors. Journal of Molecular Structure 2022;1254:132422. [DOI: 10.1016/j.molstruc.2022.132422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Singh S, Sharma A, Monga V, Bhatia R. Compendium of naringenin: Potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile. Crit Rev Food Sci Nutr 2022;:1-32. [PMID: 35357240 DOI: 10.1080/10408398.2022.2056726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Wu D, Chen J, Luo K, Li H, Liu T, Li L, Dai Z, Li Y, Zhao Y, Fu X. Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer's disease. Bioorg Chem 2022;122:105760. [PMID: 35349945 DOI: 10.1016/j.bioorg.2022.105760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhu C, Yang Y, Li X, Chen X, Lin X, Wu X. Develop potential multi-target drugs by self-assembly of quercetin with amino acids and metal ion to achieve significant efficacy in anti-Alzheimer’s disease. Nano Res . [DOI: 10.1007/s12274-021-4066-8] [Reference Citation Analysis]
17 George G, Koyiparambath VP, Sukumaran S, Nair AS, Pappachan LK, Al-Sehemi AG, Kim H, Mathew B. Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors. Int J Mol Sci 2022;23:3121. [PMID: 35328542 DOI: 10.3390/ijms23063121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Yang J, Zhou Y, Ban Y, Mi J, He Y, Li X, Liu Z, Wang K, Zhu G, Liu W, Tan Z, Sang Z. Development of naringenin-O-alkylamine derivatives as multifunctional agents for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem 2022;37:792-816. [PMID: 35193434 DOI: 10.1080/14756366.2022.2041627] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Dorababu A. Promising heterocycle-based scaffolds in recent (2019-2021) anti-Alzheimer's drug design and discovery. Eur J Pharmacol 2022;:174847. [PMID: 35218718 DOI: 10.1016/j.ejphar.2022.174847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mi J, He Y, Yang J, Zhou Y, Zhu G, Wu A, Liu W, Sang Z. Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease. Bioorg Med Chem Lett 2022;:128574. [PMID: 35065231 DOI: 10.1016/j.bmcl.2022.128574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Sang Z, Song Q, Cao Z, Deng Y, Zhang L. Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem 2022;37:69-85. [PMID: 34894968 DOI: 10.1080/14756366.2021.1993845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Zhu G, Li X, Yang J, He Y, Mi J, Tang L, Sang Z. Development of novel 2-acetylphenol-O-alkylhydroxyethylamine derivatives as multifunctional agents for Alzheimer’s disease treatment. Med Chem Res. [DOI: 10.1007/s00044-021-02786-7] [Reference Citation Analysis]
23 Zheng J, Xu W, Liu W, Tang H, Lu J, Yu K, Song X, Li F, Wang Y, Wang R, Chen L, Zhang H, Qiu Y, Wei G, Zhou X, Yang J. Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology. Biosci Rep 2021;41:BSR20204421. [PMID: 34002799 DOI: 10.1042/BSR20204421] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
24 Rioux B, Pinon A, Gamond A, Martin F, Laurent A, Champavier Y, Barette C, Liagre B, Fagnère C, Sol V, Pouget C. Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy. Eur J Med Chem 2021;222:113586. [PMID: 34116328 DOI: 10.1016/j.ejmech.2021.113586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
25 Wang K, Shi J, Zhou Y, He Y, Mi J, Yang J, Liu S, Tang X, Liu W, Tan Z, Sang Z. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease. Bioorg Chem 2021;112:104879. [PMID: 33915461 DOI: 10.1016/j.bioorg.2021.104879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
26 Bures J, Tacheci I, Kvetina J, Radochova V, Prchal L, Kohoutova D, Valis M, Novak M, Dolezal R, Kopacova M, Rejchrt S, Sestak V, Knoblochova V, Peterova E, Zdarova Karasova J. The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-O-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental Pigs. Molecules 2021;26:2160. [PMID: 33918638 DOI: 10.3390/molecules26082160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Cao Z, Song Q, Yu G, Liu Z, Cong S, Tan Z, Deng Y. Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. Bioorg Med Chem 2021;35:116074. [PMID: 33640707 DOI: 10.1016/j.bmc.2021.116074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
28 Sang Z, Song Q, Cao Z, Deng Y, Tan Z, Zhang L. Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer's disease. Eur J Med Chem 2021;216:113310. [PMID: 33667847 DOI: 10.1016/j.ejmech.2021.113310] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
29 Abdpour S, Jalili-Baleh L, Nadri H, Forootanfar H, Bukhari SNA, Ramazani A, Ebrahimi SES, Foroumadi A, Khoobi M. Chromone derivatives bearing pyridinium moiety as multi-target-directed ligands against Alzheimer's disease. Bioorg Chem 2021;110:104750. [PMID: 33691251 DOI: 10.1016/j.bioorg.2021.104750] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
30 Jalili-Baleh L, Nadri H, Forootanfar H, Küçükkılınç TT, Ayazgök B, Sharifzadeh M, Rahimifard M, Baeeri M, Abdollahi M, Foroumadi A, Khoobi M. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities. Daru 2021;29:23-38. [PMID: 33420969 DOI: 10.1007/s40199-020-00378-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
31 Sang Z, Shi J, Zhou Y, Wang K, Zhao Y, Li Q, Qiao Z, Wu A, Tan Z, Liu W. Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease. Bioorg Chem 2021;107:104602. [PMID: 33453647 DOI: 10.1016/j.bioorg.2020.104602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
32 Du H, Jiang X, Ma M, Xu H, Liu S, Ma F. Novel deoxyvasicinone and tetrahydro-beta-carboline hybrids as inhibitors of acetylcholinesterase and amyloid beta aggregation. Bioorg Med Chem Lett 2020;30:127659. [PMID: 33137375 DOI: 10.1016/j.bmcl.2020.127659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Shi J, Zhou Y, Wang K, Ma Q, Wei R, Li Q, Zhao Y, Qiao Z, Liu S, Leng Y, Liu W, Sang Z. Design, synthesis and biological evaluation of Schiff’s base derivatives as multifunctional agents for the treatment of Alzheimer’s disease. Med Chem Res 2021;30:624-34. [DOI: 10.1007/s00044-020-02666-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Liu W, Xu W, Li C, Xu J, Huang K, Hu R, Huang H, Liu X. Network pharmacological systems study of Huang-Lian-Tang in the treatment of glioblastoma multiforme. Oncol Lett 2021;21:18. [PMID: 33240424 DOI: 10.3892/ol.2020.12279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Karimi Askarani H, Iraji A, Rastegari A, Abbas Bukhari SN, Firuzi O, Akbarzadeh T, Saeedi M. Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease. BMC Chem 2020;14:64. [PMID: 33134975 DOI: 10.1186/s13065-020-00715-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
36 Yamali C, Engin FS, Bilginer S, Tugrak M, Ozmen Ozgun D, Ozli G, Levent S, Saglik BN, Ozkay Y, Gul HI. Phenothiazine‐based chalcones as potential dual‐target inhibitors toward cholinesterases (AChE, BuChE) and monoamine oxidases (MAO‐A, MAO‐B). J Heterocyclic Chem 2021;58:161-71. [DOI: 10.1002/jhet.4156] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]